Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Aug 8:5:98.
doi: 10.1186/1471-2407-5-98.

Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics

Nil Culhaci  1 , Ozgul Sagol, Sedat Karademir, Huseyin Astarcioglu, Ibrahim Astarcioglu, Mujde Soyturk, Ilhan Oztop, Funda Obuz
Affiliations

Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics

Nil Culhaci et al. BMC Cancer. .

Abstract

Background: The purpose of our study was to investigate the immunohistochemical expression of TGF-beta1 and p27 in pancreatic adenocarcinomas and to compare the findings with the clinicopathological features and survival. We also aimed to evaluate the expression of TGF-beta1 and p27 in the context of other cell cycle and proliferation markers such as cyclin D1 and Ki-67.

Methods: We examined TGF-beta1 and p27 expression immunohistochemically in 63 cases of invasive ductal adenocarcinoma of the pancreas. Standard streptavidin-biotin immunperoxidase method was used for immunostaining and the stained slides were examined microscopically using semiquantitative criteria.

Results: TGF-beta1 stained the cytoplasms of the tumor cells in 43 cases [68.3%]. There was a statistically significant difference among TGF-beta1 staining scores in terms of clinicopathologic factors such as blood vessel invasion, stage and distant metastasis [p < 0.05]. Of the 63 tumors evaluated 23 [36.5%] were positive for p27 within the nucleus. An inverse correlation was found between p27 immunoreactivity and grade [p < 0.05]. But no significant correlation was found between p27 and other parameters. Among the patients with survival data 27 patients had RO resections and these cases were considered in survival analysis. In the univariate analysis, neither TGF-beta1 nor p27 expression was related with patient survival.

Conclusion: Our findings suggest that in pancreatic carcinoma, TGF-beta1 expression is related to tumor growth and metastasis. But it is not associated with cell cycle proteins. p27 expression is reduced in pancreatic adenocarcinomas and decreased protein levels of p27 may play a role in the differentiation of pancreatic cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Intense [score 6] cytoplasmic TGF-β1 immunoreactivity of pancreatic ductal carcinoma cells [anti-TGF-β1, original magnification, × 400].
Figure 2
Figure 2
High level nuclear p27 immunoreactivity of pancreatic carcinoma cells [anti-p27, original magnification, × 400].
See this image and copyright information in PMC

References

    1. Solcia E, Capella C, Klöppel G. Atlas of Tumor Pathology Tumors of the Pancreas Third series, fascicle 20. Washington, D.C: AFIP; 1997. Tumors of the exocrine pancreas; pp. 64–88.
    1. Ozawa F, Friess H, Tempia-Caliera A, Kleeff J, Büchler MW. Growth factors and their receptors in pancreatic cancer. Teratog Carcinog Mutagen. 2001;21:27–44. doi: 10.1002/1520-6866(2001)21:1<27::AID-TCM4>3.0.CO;2-9. - DOI - PubMed
    1. Itakura J, Ishiwata T, Shen B, Kornmann M, Korc M. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int J Cancer. 2000;85:27–34. doi: 10.1002/(SICI)1097-0215(20000101)85:1<27::AID-IJC5>3.0.CO;2-8. - DOI - PubMed
    1. Karademir S, Sökmen S, Terzi C, Sağol Ö, Özer E, Astarcıoğlu H, Çoker A, Astarcıoğlu İ. Tumor angiogenesis as a prognostic predictor in pancreatic cancer. J Hepatobiliary Pancreat Surg. 2000;7:489–495. doi: 10.1007/s005340070020. - DOI - PubMed
    1. Apple SK, Hecht JR, Lewin DN, Jahromi SA, Grody WW, Nieberg RK. Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis. Hum Pathol. 1999;30:123–129. doi: 10.1016/S0046-8177(99)90265-4. - DOI - PubMed

MeSH terms